Health
Weight Watchers Expands Its Integrated GLP-1 Platform with Access to Wegovy® Pill Advancing a New Standard for Long-Term Weight Health
A NovoCare® Recognized Care Provider, Weight Watchers’ new Med+ program delivers an integrated GLP-1 care model proven to drive greater weight loss results than medication aloneNEW YORK, Jan. 05, 2026 (GLOBE NEWSWIRE) -- WW International, Inc. (NASDAQ: WW) (“Weight Watchers”), the global leader in science-backed weight health, today announced access to Novo Nordisk’s newly FDA approved oral formulation of Wegovy® through its integrated GLP-1 platform. The addition of a once-daily Wegovy pill exp
About this update from Novo Nordisk A/s Class B
[{"type":"image","alt":"WW International Inc.","displaySize":"","headline":null,"caption":"WW International Inc.","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":55,"url":"https://media.zenfs.com/en/globenewswire.com/6a866065e6a3540f87dba185bc3de450"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/xqXHzc0EPK4qQQTcfr2b6w--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTc3O2NmPXdlYnA-/https://media.zenfs.com/en/globenewswire.com/6a866065e6a3540f87dba185bc3de450","width":300,"height":55}},"lazy":false},{"type":"text","content":"A NovoCare® Recognized Care Provider, Weight Watchers’ new Med+ program delivers an integrated GLP-1 care model proven to drive greater weight loss results than medication alone","length":177,"tagName":"p"},{"type":"text","content":"NEW YORK, Jan. 05, 2026 (GLOBE NEWSWIRE) -- WW International, Inc. (NASDAQ: WW) (“Weight Watchers”), the global leader in science-backed weight health, today announced access to Novo Nordisk’s newly FDA approved oral formulation of Wegovy® through its integrated GLP-1 platform. The addition of a once-daily Wegovy pill expands access to GLP-1 treatment and reinforces Weight Watchers’ leadership in delivering comprehensive care models that help people succeed on medication in real life by pairing medical therapy with evidence-based behavior change and ongoing support.","length":572,"tagName":"p"},{"type":"text","content":"Weight Watchers, through its affiliated Weight Watchers Clinic, is a NovoCare® Recognized Care Provider based on its demonstrated ability to deliver FDA-approved GLP-1 medications alongside expert clinical care. Through Weight Watchers Med+ and the GLP-1 Success Program, the company delivers differentiated real-world outcomes by combining access to board-certified physicians and clinicians, evidence-based behavioral science, coaching and community support, and purpose-built digital tools. Together this integrated care model helps members stay engaged, manage side effects, and achieve meaningfully better results than medication alone.“The next era of weight health isn’t about access to medication alone, it’s about helping people succeed on it,” said Tara Comonte, CEO of Weight Watchers. “For decades, Weight Watchers has shown that support drives results and we’re seeing that same truth play out in the GLP-1 era. By pairing access to GLP-1 medications with our prov...